Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss

v3.8.0.1
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Sales $ 221,847 $ 18,283 $ 309,367 $ 182,474
Cost of Sales 59,825 12,019 89,125 70,894
Gross Margin 162,022 6,264 220,242 111,580
Operating expenses        
Sales and marketing 435,294 187,265 880,817 269,463
Research and development 715,400 813,773 1,401,309 1,231,563
General and administrative 1,505,528 577,853 2,133,134 1,881,467
Share compensation expense (Note 11) 762,208 204,842 1,013,256 424,090
Convertible debt accretion (Note 8) 74,073 0 74,073 0
Amortization (Note 4) 76,985 0 169,934 0
Depreciation (Note 7) 23,820 23,590 48,372 33,753
Total operating expenses 3,593,308 1,807,323 5,720,895 3,840,336
Other expenses (income)        
Foreign Exchange 15,595 0 114,156 0
Interest expense (income) (Note 8) 167,594 (5,203) 240,360 10,031
Other income 886 (395,296) 708 (406,514)
Total other expenses (income) 184,075 (400,499) 355,224 (396,483)
Net loss and comprehensive loss for the period $ (3,615,361) $ (1,400,560) $ (5,855,877) $ (3,332,273)
Loss per share - basic $ (0.04) $ (0.02) $ (0.06) $ (0.04)
Loss per share - diluted $ (0.04) $ (0.02) $ (0.06) $ (0.04)
Weighted average number of shares outstanding - basic 101,794,615 85,924,462 99,335,514 87,232,426
Weighted average number of shares outstanding - diluted 101,794,615 85,924,462 99,335,514 87,232,426